AN2 Therapeutics, Inc. (ANTX)

NASDAQ:ANTX

US Market

ANTX

AN2 Therapeutics, Inc.

RESEARCH TOOLSreports

Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Ownership - Who Owns AN2 Therapeutics, Inc.?

106 Followers

AN2 Therapeutics, Inc. (ANTX) Ownership Overview

18.13% Insiders

3.55% Mutual Funds

41.18% Other Institutional Investors

3.04% ETFs

34.11% Public Companies and

Individual Investors

The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 47.76% of the company’s stock is owned by Institutional Investors, 18.13% is owned by Insiders, and 34.11% is owned by Public Companies and Individual Investors.

The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 44.73% of the company’s stock is owned by Institutional Investors, 18.13% is owned by Insiders, and 3.04% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 02, 2026	Sarah Joanne Williams	xxxxxxxxxxxxx	$1174
Mar 05, 2026	Sarah Joanne Williams	xxxxxxxxxxxxx	$347
Jan 07, 2026	Stephen David Prior	xxxxxxxxxxxxx	$6491
Jan 07, 2026	Eizen Joshua M	xxxxxxxxxxxxx	$24923

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Sep 30, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$3398355

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	2,429,754	Insider	6.75%	11,905,795
	1,628,512	Insider	4.52%	7,979,709
	1,243,938	Insider	3.45%	6,095,296
	998,820	Institution	2.77%	4,894,218
Michael Rockefeller	993,671	Institution	2.76%	4,868,988
	985,504	Institution	2.74%	4,828,970
	551,418	Insider	1.53%	2,701,948
	207,543	Institution	0.58%	1,016,961
	207,499	Insider	0.58%	1,016,745
	118,823	Insider	0.33%	582,233

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	985,504	Institution	2.74%	4,828,970
	207,543	Institution	0.58%	1,016,961
	59,000	Institution	0.16%	289,100
	12,793	Institution	0.04%	62,686
	12,781	Institution	0.04%	62,627
	1,347	Institution	<0.01%	6,600

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	733,392	Institution	2.04%	3,175,587
Vanguard Extended Market ETF	265,428	Institution	0.74%	1,149,303
iShares Micro-Cap ETF	53,165	Institution	0.15%	260,509
Dimensional U.S. Small Cap ETF	35,294	Institution	0.10%	167,999
Dimensional U.S. Core Equity 2 ETF	3,416	Institution	<0.01%	16,260
U.S. Micro Cap Portfolio ETF	3,382	Institution	<0.01%	11,566
-	4	Institution	<0.01%	20

FAQ

Who Owns AN2 Therapeutics, Inc. (ANTX)?

According to the latest TipRanks data, approximately 41.18% of the company's stock is held by institutional investors, 18.13% is held by insiders, and 34.11% is held by retail investors.

What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 41.18% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.

What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 34.11% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.

Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?

Kabeer Aziz owns the most shares of AN2 Therapeutics, Inc. (ANTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.